Global Biosimilar Testing and Development Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Biosimilar Testing and Development Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biosimilar Testing and Development Services market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. PK assay accounting for % of the Biosimilar Testing and Development Services global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Effector Binding segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biosimilar Testing and Development Services include Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, and Exova, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilar Testing and Development Services market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Market segment by Application, can be divided into
PK assay
Tiered Immunogenicity testing
NAb assays
Market segment by players, this report covers
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar Testing and Development Services product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar Testing and Development Services, with revenue, gross margin and global market share of Biosimilar Testing and Development Services from 2019 to 2022.
Chapter 3, the Biosimilar Testing and Development Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilar Testing and Development Services market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilar Testing and Development Services research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Biosimilar Testing and Development Services
1.2 Classification of Biosimilar Testing and Development Services by Type
1.2.1 Overview: Global Biosimilar Testing and Development Services Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biosimilar Testing and Development Services Revenue Market Share by Type in 2021
1.2.3 Effector Binding
1.2.4 ELISA
1.2.5 Kinetic Binding Assays
1.2.6 ADCC & CDC Cell-Based Assays
1.3 Global Biosimilar Testing and Development Services Market by Application
1.3.1 Overview: Global Biosimilar Testing and Development Services Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Global Biosimilar Testing and Development Services Market Size & Forecast
1.5 Global Biosimilar Testing and Development Services Market Size and Forecast by Region
1.5.1 Global Biosimilar Testing and Development Services Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biosimilar Testing and Development Services Market Size by Region, (2017-2022)
1.5.3 North America Biosimilar Testing and Development Services Market Size and Prospect (2017-2028)
1.5.4 Europe Biosimilar Testing and Development Services Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biosimilar Testing and Development Services Market Size and Prospect (2017-2028)
1.5.6 South America Biosimilar Testing and Development Services Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biosimilar Testing and Development Services Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilar Testing and Development Services Market Drivers
1.6.2 Biosimilar Testing and Development Services Market Restraints
1.6.3 Biosimilar Testing and Development Services Trends Analysis
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business
2.1.3 Eurofins Scientific Biosimilar Testing and Development Services Product and Solutions
2.1.4 Eurofins Scientific Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eurofins Scientific Recent Developments and Future Plans
2.2 SGS
2.2.1 SGS Details
2.2.2 SGS Major Business
2.2.3 SGS Biosimilar Testing and Development Services Product and Solutions
2.2.4 SGS Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 SGS Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Biosimilar Testing and Development Services Product and Solutions
2.3.4 Charles River Laboratories Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Pharmaceutical Product Development
2.4.1 Pharmaceutical Product Development Details
2.4.2 Pharmaceutical Product Development Major Business
2.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Product and Solutions
2.4.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pharmaceutical Product Development Recent Developments and Future Plans
2.5 Exova
2.5.1 Exova Details
2.5.2 Exova Major Business
2.5.3 Exova Biosimilar Testing and Development Services Product and Solutions
2.5.4 Exova Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Exova Recent Developments and Future Plans
2.6 Source BioScience
2.6.1 Source BioScience Details
2.6.2 Source BioScience Major Business
2.6.3 Source BioScience Biosimilar Testing and Development Services Product and Solutions
2.6.4 Source BioScience Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Source BioScience Recent Developments and Future Plans
2.7 Intertek Group
2.7.1 Intertek Group Details
2.7.2 Intertek Group Major Business
2.7.3 Intertek Group Biosimilar Testing and Development Services Product and Solutions
2.7.4 Intertek Group Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Intertek Group Recent Developments and Future Plans
2.8 Medistri
2.8.1 Medistri Details
2.8.2 Medistri Major Business
2.8.3 Medistri Biosimilar Testing and Development Services Product and Solutions
2.8.4 Medistri Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Medistri Recent Developments and Future Plans
2.9 Pace Analytical Services
2.9.1 Pace Analytical Services Details
2.9.2 Pace Analytical Services Major Business
2.9.3 Pace Analytical Services Biosimilar Testing and Development Services Product and Solutions
2.9.4 Pace Analytical Services Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pace Analytical Services Recent Developments and Future Plans
2.10 Sigma-Aldrich
2.10.1 Sigma-Aldrich Details
2.10.2 Sigma-Aldrich Major Business
2.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Product and Solutions
2.10.4 Sigma-Aldrich Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sigma-Aldrich Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosimilar Testing and Development Services Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biosimilar Testing and Development Services Players Market Share in 2021
3.2.2 Top 10 Biosimilar Testing and Development Services Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biosimilar Testing and Development Services Players Head Office, Products and Services Provided
3.4 Biosimilar Testing and Development Services Mergers & Acquisitions
3.5 Biosimilar Testing and Development Services New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biosimilar Testing and Development Services Revenue and Market Share by Type (2017-2022)
4.2 Global Biosimilar Testing and Development Services Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biosimilar Testing and Development Services Revenue Market Share by Application (2017-2022)
5.2 Global Biosimilar Testing and Development Services Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biosimilar Testing and Development Services Revenue by Type (2017-2028)
6.2 North America Biosimilar Testing and Development Services Revenue by Application (2017-2028)
6.3 North America Biosimilar Testing and Development Services Market Size by Country
6.3.1 North America Biosimilar Testing and Development Services Revenue by Country (2017-2028)
6.3.2 United States Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
6.3.3 Canada Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
6.3.4 Mexico Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biosimilar Testing and Development Services Revenue by Type (2017-2028)
7.2 Europe Biosimilar Testing and Development Services Revenue by Application (2017-2028)
7.3 Europe Biosimilar Testing and Development Services Market Size by Country
7.3.1 Europe Biosimilar Testing and Development Services Revenue by Country (2017-2028)
7.3.2 Germany Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
7.3.3 France Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
7.3.5 Russia Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
7.3.6 Italy Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biosimilar Testing and Development Services Revenue by Type (2017-2028)
8.2 Asia-Pacific Biosimilar Testing and Development Services Revenue by Application (2017-2028)
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region
8.3.1 Asia-Pacific Biosimilar Testing and Development Services Revenue by Region (2017-2028)
8.3.2 China Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
8.3.3 Japan Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
8.3.4 South Korea Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
8.3.5 India Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
8.3.7 Australia Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biosimilar Testing and Development Services Revenue by Type (2017-2028)
9.2 South America Biosimilar Testing and Development Services Revenue by Application (2017-2028)
9.3 South America Biosimilar Testing and Development Services Market Size by Country
9.3.1 South America Biosimilar Testing and Development Services Revenue by Country (2017-2028)
9.3.2 Brazil Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
9.3.3 Argentina Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biosimilar Testing and Development Services Revenue by Type (2017-2028)
10.2 Middle East & Africa Biosimilar Testing and Development Services Revenue by Application (2017-2028)
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country
10.3.1 Middle East & Africa Biosimilar Testing and Development Services Revenue by Country (2017-2028)
10.3.2 Turkey Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
10.3.4 UAE Biosimilar Testing and Development Services Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Testing and Development Services Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biosimilar Testing and Development Services Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biosimilar Testing and Development Services Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biosimilar Testing and Development Services Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biosimilar Testing and Development Services Revenue Market Share by Region (2023-2028)
Table 6. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Eurofins Scientific Major Business
Table 8. Eurofins Scientific Biosimilar Testing and Development Services Product and Solutions
Table 9. Eurofins Scientific Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. SGS Corporate Information, Head Office, and Major Competitors
Table 11. SGS Major Business
Table 12. SGS Biosimilar Testing and Development Services Product and Solutions
Table 13. SGS Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Laboratories Major Business
Table 16. Charles River Laboratories Biosimilar Testing and Development Services Product and Solutions
Table 17. Charles River Laboratories Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pharmaceutical Product Development Corporate Information, Head Office, and Major Competitors
Table 19. Pharmaceutical Product Development Major Business
Table 20. Pharmaceutical Product Development Biosimilar Testing and Development Services Product and Solutions
Table 21. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Exova Corporate Information, Head Office, and Major Competitors
Table 23. Exova Major Business
Table 24. Exova Biosimilar Testing and Development Services Product and Solutions
Table 25. Exova Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Source BioScience Corporate Information, Head Office, and Major Competitors
Table 27. Source BioScience Major Business
Table 28. Source BioScience Biosimilar Testing and Development Services Product and Solutions
Table 29. Source BioScience Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Intertek Group Corporate Information, Head Office, and Major Competitors
Table 31. Intertek Group Major Business
Table 32. Intertek Group Biosimilar Testing and Development Services Product and Solutions
Table 33. Intertek Group Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Medistri Corporate Information, Head Office, and Major Competitors
Table 35. Medistri Major Business
Table 36. Medistri Biosimilar Testing and Development Services Product and Solutions
Table 37. Medistri Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pace Analytical Services Corporate Information, Head Office, and Major Competitors
Table 39. Pace Analytical Services Major Business
Table 40. Pace Analytical Services Biosimilar Testing and Development Services Product and Solutions
Table 41. Pace Analytical Services Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sigma-Aldrich Corporate Information, Head Office, and Major Competitors
Table 43. Sigma-Aldrich Major Business
Table 44. Sigma-Aldrich Biosimilar Testing and Development Services Product and Solutions
Table 45. Sigma-Aldrich Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Biosimilar Testing and Development Services Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Biosimilar Testing and Development Services Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Biosimilar Testing and Development Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Biosimilar Testing and Development Services Players Head Office, Products and Services Provided
Table 50. Biosimilar Testing and Development Services Mergers & Acquisitions in the Past Five Years
Table 51. Biosimilar Testing and Development Services New Entrants and Expansion Plans
Table 52. Global Biosimilar Testing and Development Services Revenue (USD Million) by Type (2017-2022)
Table 53. Global Biosimilar Testing and Development Services Revenue Share by Type (2017-2022)
Table 54. Global Biosimilar Testing and Development Services Revenue Forecast by Type (2023-2028)
Table 55. Global Biosimilar Testing and Development Services Revenue by Application (2017-2022)
Table 56. Global Biosimilar Testing and Development Services Revenue Forecast by Application (2023-2028)
Table 57. North America Biosimilar Testing and Development Services Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Biosimilar Testing and Development Services Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Biosimilar Testing and Development Services Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Biosimilar Testing and Development Services Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Biosimilar Testing and Development Services Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Biosimilar Testing and Development Services Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Biosimilar Testing and Development Services Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Biosimilar Testing and Development Services Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Biosimilar Testing and Development Services Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Biosimilar Testing and Development Services Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Biosimilar Testing and Development Services Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Biosimilar Testing and Development Services Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Biosimilar Testing and Development Services Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Biosimilar Testing and Development Services Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Biosimilar Testing and Development Services Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Biosimilar Testing and Development Services Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Biosimilar Testing and Development Services Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Biosimilar Testing and Development Services Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Biosimilar Testing and Development Services Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Biosimilar Testing and Development Services Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Biosimilar Testing and Development Services Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Biosimilar Testing and Development Services Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Biosimilar Testing and Development Services Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Biosimilar Testing and Development Services Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Biosimilar Testing and Development Services Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Biosimilar Testing and Development Services Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Biosimilar Testing and Development Services Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Biosimilar Testing and Development Services Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Biosimilar Testing and Development Services Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Biosimilar Testing and Development Services Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biosimilar Testing and Development Services Picture
Figure 2. Global Biosimilar Testing and Development Services Revenue Market Share by Type in 2021
Figure 3. Effector Binding
Figure 4. ELISA
Figure 5. Kinetic Binding Assays
Figure 6. ADCC & CDC Cell-Based Assays
Figure 7. Biosimilar Testing and Development Services Revenue Market Share by Application in 2021
Figure 8. PK assay Picture
Figure 9. Tiered Immunogenicity testing Picture
Figure 10. NAb assays Picture
Figure 11. Global Biosimilar Testing and Development Services Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Biosimilar Testing and Development Services Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Biosimilar Testing and Development Services Revenue Market Share by Region (2017-2028)
Figure 14. Global Biosimilar Testing and Development Services Revenue Market Share by Region in 2021
Figure 15. North America Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Biosimilar Testing and Development Services Market Drivers
Figure 21. Biosimilar Testing and Development Services Market Restraints
Figure 22. Biosimilar Testing and Development Services Market Trends
Figure 23. Eurofins Scientific Recent Developments and Future Plans
Figure 24. SGS Recent Developments and Future Plans
Figure 25. Charles River Laboratories Recent Developments and Future Plans
Figure 26. Pharmaceutical Product Development Recent Developments and Future Plans
Figure 27. Exova Recent Developments and Future Plans
Figure 28. Source BioScience Recent Developments and Future Plans
Figure 29. Intertek Group Recent Developments and Future Plans
Figure 30. Medistri Recent Developments and Future Plans
Figure 31. Pace Analytical Services Recent Developments and Future Plans
Figure 32. Sigma-Aldrich Recent Developments and Future Plans
Figure 33. Global Biosimilar Testing and Development Services Revenue Share by Players in 2021
Figure 34. Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Biosimilar Testing and Development Services Revenue Market Share in 2021
Figure 36. Global Top 10 Players Biosimilar Testing and Development Services Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Biosimilar Testing and Development Services Revenue Share by Type in 2021
Figure 39. Global Biosimilar Testing and Development Services Market Share Forecast by Type (2023-2028)
Figure 40. Global Biosimilar Testing and Development Services Revenue Share by Application in 2021
Figure 41. Global Biosimilar Testing and Development Services Market Share Forecast by Application (2023-2028)
Figure 42. North America Biosimilar Testing and Development Services Sales Market Share by Type (2017-2028)
Figure 43. North America Biosimilar Testing and Development Services Sales Market Share by Application (2017-2028)
Figure 44. North America Biosimilar Testing and Development Services Revenue Market Share by Country (2017-2028)
Figure 45. United States Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Biosimilar Testing and Development Services Sales Market Share by Type (2017-2028)
Figure 49. Europe Biosimilar Testing and Development Services Sales Market Share by Application (2017-2028)
Figure 50. Europe Biosimilar Testing and Development Services Revenue Market Share by Country (2017-2028)
Figure 51. Germany Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Biosimilar Testing and Development Services Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Biosimilar Testing and Development Services Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Biosimilar Testing and Development Services Revenue Market Share by Region (2017-2028)
Figure 59. China Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Biosimilar Testing and Development Services Sales Market Share by Type (2017-2028)
Figure 66. South America Biosimilar Testing and Development Services Sales Market Share by Application (2017-2028)
Figure 67. South America Biosimilar Testing and Development Services Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Biosimilar Testing and Development Services Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Biosimilar Testing and Development Services Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Biosimilar Testing and Development Services Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Biosimilar Testing and Development Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
